{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:49:17Z","timestamp":1789350557286,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1053\/j.semnuclmed.2024.12.001","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T09:35:13Z","timestamp":1738316113000},"page":"371-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update"],"prefix":"10.1053","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-2011","authenticated-orcid":false,"given":"Jianliang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon T.S.","family":"Woon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-5618","authenticated-orcid":false,"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0002","first-page":"81","article-title":"Cordon-cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"issue":"10231","key":"10.1053\/j.semnuclmed.2024.12.001_bib0003","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0005","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive (68)ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","author":"Perera","year":"2016","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/B978-0-12-818438-7.00002-2","article-title":"The rise of artificial intelligence in healthcare applications","author":"Bohr","year":"2020","journal-title":"Artif Intel Healthcare"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOU.0000000000001144","article-title":"AI-powered radiomics: revolutionizing detection of urologic malignancies","volume":"34","author":"Gelikman","year":"2024","journal-title":"Curr Opin Urol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.12.001_bib0009","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bju.16412","article-title":"A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer","volume":"134","author":"Liu","year":"2024","journal-title":"BJU Int"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.12.001_bib0010","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/cancers16030486","article-title":"Lawrentschuk N. A systematic review on artificial intelligence evaluating metastatic prostatic cancer and lymph nodes on PSMA PET scans","volume":"16","author":"Liu","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, Part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, Version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2967\/jnumed.120.261863","article-title":"aPROMISE: a novel automated PROMISE platform to standardize evaluation of tumor burden in (18)F-DCFPyL images of veterans with prostate cancer","volume":"63","author":"Nickols","year":"2022","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0015","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/s41598-024-53683-z","article-title":"Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET\/CT. A pilot study","volume":"14","author":"Garc\u00eda Vicente","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.12.001_bib0016","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00259-021-05497-8","article-title":"Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting","volume":"49","author":"Johnsson","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2024.12.001_bib0017","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamaoncol.2020.7857","article-title":"Association of bone metastatic burden with survival benefit from prostate radiotherapy in patients with newly diagnosed metastatic prostate cancer: a secondary analysis of a randomized clinical trial","volume":"7","author":"Ali","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.12.001_bib0018","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.12.001_bib0019","first-page":"2101","article-title":"Freely available, fully automated ai-based analysis of primary tumour and metastases of prostate cancer in whole-body [(18)F]-PSMA-1007 PET-CT","volume":"12","author":"Tr\u00e4g\u00e5rdh","year":"2022","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"3","key":"10.1053\/j.semnuclmed.2024.12.001_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/tomography7030027","article-title":"Evaluating a machine learning tool for the classification of pathological uptake in Whole-Body PSMA-PET-CT scans","volume":"7","author":"Erle","year":"2021","journal-title":"Tomography."},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.12.001_bib0021","first-page":"622","article-title":"Machine learning facilitates hotspot classification in PSMA-PET\/CT with nuclear medicine specialist accuracy","volume":"10","author":"Moazemi","year":"2020","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0022","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00259-021-05473-2","article-title":"Whole-body uptake classification and prostate cancer staging in (68)Ga-PSMA-11 PET\/CT using dual-tracer learning","volume":"49","author":"Capobianco","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.12.001_bib0023","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s10278-024-01104-y","article-title":"An automated deep learning-based framework for uptake segmentation and classification on PSMA PET\/CT imaging of patients with prostate cancer","volume":"37","author":"Li","year":"2024","journal-title":"J Imaging Inform Med"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106882","article-title":"Automatic segmentation of prostate cancer metastases in PSMA PET\/CT images using deep neural networks with weighted batch-wise dice loss","volume":"158","author":"Xu","year":"2023","journal-title":"Comput Biol Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2024.12.001_bib0025","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00345-018-2524-z","article-title":"PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics","volume":"37","author":"Eapen","year":"2019","journal-title":"World J Urol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2024.12.001_bib0026","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1007\/s00259-022-05883-w","article-title":"Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with (177)Lu-PSMA I&T therapy","volume":"49","author":"Xue","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2024.12.001_bib0027","doi-asserted-by":"crossref","first-page":"818","DOI":"10.21037\/atm-20-6446","article-title":"Decision-support for treatment with (177)Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET\/CT and clinical parameters","volume":"9","author":"Moazemi","year":"2021","journal-title":"Ann Transl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2024.12.001_bib0028","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","article-title":"Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"4","author":"Mazzone","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2024.12.001_bib0029","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S","article-title":"Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases","volume":"82","author":"Bostwick","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2024.12.001_bib0031","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s11547-022-01541-1","article-title":"Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with (18)F-PSMA-1007 PET: comparison among different volume segmentation thresholds","volume":"127","author":"Yao","year":"2022","journal-title":"Radiol Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0032","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13550-023-00984-5","article-title":"Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy","volume":"13","author":"Chan","year":"2023","journal-title":"EJNMMI Res"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.12.001_bib0033","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","article-title":"Role of [(68)Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer","volume":"50","author":"Ghezzo","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0034","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00259-020-04971-z","article-title":"Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer","volume":"48","author":"Cysouw","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00259-021-05430-z","article-title":"The added value of PSMA PET\/MR radiomics for prostate cancer staging","volume":"49","author":"Solari","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13139-023-00832-3","article-title":"Convoluted neural network for detection of clinically significant prostate cancer on 68 Ga PSMA PET\/CT delayed imaging by analyzing radiomic features","volume":"58","author":"Kumar","year":"2024","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0037","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s43657-023-00108-y","article-title":"Performance of (18)F-DCFPyL PET\/CT in primary prostate cancer diagnosis, Gleason grading and D'amico classification: a radiomics-based study","volume":"3","author":"Li","year":"2023","journal-title":"Phenomics"},{"issue":"2","key":"10.1053\/j.semnuclmed.2024.12.001_bib0038","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s13246-024-01402-3","article-title":"Machine learning-based analysis of (68)Ga-PSMA-11 PET\/CT images for estimation of prostate tumor grade","volume":"47","author":"Khateri","year":"2024","journal-title":"Phys Eng Sci Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0039","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00259-023-06392-0","article-title":"The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis","volume":"51","author":"Gossili","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110070","article-title":"Using multiparametric magnetic resonance imaging and prostate specific membrane antigen positron emission tomography to detect and delineate the gross tumour volume of intraprostatic lesions - a systematic review and meta-analysis","volume":"192","author":"Dhar","year":"2024","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0041","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2967\/jnumed.120.254623","article-title":"Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network","volume":"62","author":"Kostyszyn","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0042","article-title":"External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on (68)Ga-PSMA PET images","volume":"10","author":"Ghezzo","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1053\/j.semnuclmed.2024.12.001_bib0043","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13014-024-02491-w","article-title":"The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on (18)F-PSMA-1007 PET","volume":"19","author":"Holzschuh","year":"2024","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0044","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"issue":"21","key":"10.1053\/j.semnuclmed.2024.12.001_bib0045","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.3390\/cancers16213596","article-title":"Predicting biochemical recurrence of prostate cancer post-prostatectomy using artificial intelligence: a systematic review","volume":"16","author":"Liu","year":"2024","journal-title":"Cancers"},{"issue":"6","key":"10.1053\/j.semnuclmed.2024.12.001_bib0046","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","article-title":"Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-PSMA-11 PET\/MRI","volume":"48","author":"Papp","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0047","doi-asserted-by":"crossref","first-page":"e60323","DOI":"10.2196\/60323","article-title":"A machine learning approach for predicting biochemical outcome after PSMA-PET-guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study","volume":"10","author":"Janbain","year":"2024","journal-title":"JMIR Cancer"},{"issue":"8","key":"10.1053\/j.semnuclmed.2024.12.001_bib0048","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5694\/mja2.51722","article-title":"Modern paradigms for prostate cancer detection and management","volume":"217","author":"Williams","year":"2022","journal-title":"Med J Aust"},{"issue":"1152","key":"10.1053\/j.semnuclmed.2024.12.001_bib0049","article-title":"Black box no more: a scoping review of AI governance frameworks to guide procurement and adoption of AI in medical imaging and radiotherapy in the UK","volume":"96","author":"Stogiannos","year":"2023","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2024.12.001_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113172","article-title":"The ethics of AI in health care: a mapping review","volume":"260","author":"Morley","year":"2020","journal-title":"Soc Sci Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129982400120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000129982400120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:59:13Z","timestamp":1762073953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000129982400120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S000129982400120X"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.12.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}